Jane Street’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-64,916
| Closed | -$148K | – | 6722 |
|
2024
Q2 | $148K | Sell |
64,916
-268,656
| -81% | -$613K | ﹤0.01% | 5520 |
|
2024
Q1 | $1.44M | Buy |
333,572
+110,972
| +50% | +$479K | ﹤0.01% | 2737 |
|
2023
Q4 | $679K | Buy |
222,600
+212,205
| +2,041% | +$647K | ﹤0.01% | 3775 |
|
2023
Q3 | $15K | Buy |
+10,395
| New | +$15K | ﹤0.01% | 4909 |
|
2023
Q2 | – | Sell |
-56,040
| Closed | -$150K | – | 6135 |
|
2023
Q1 | $150K | Sell |
56,040
-76,084
| -58% | -$204K | ﹤0.01% | 4797 |
|
2022
Q4 | $717K | Buy |
132,124
+50,496
| +62% | +$274K | ﹤0.01% | 3014 |
|
2022
Q3 | $1.02M | Buy |
81,628
+58,383
| +251% | +$729K | ﹤0.01% | 2770 |
|
2022
Q2 | $115K | Sell |
23,245
-12,590
| -35% | -$62.3K | ﹤0.01% | 4688 |
|
2022
Q1 | $272K | Sell |
35,835
-14,222
| -28% | -$108K | ﹤0.01% | 4403 |
|
2021
Q4 | $511K | Sell |
50,057
-14,780
| -23% | -$151K | ﹤0.01% | 3441 |
|
2021
Q3 | $870K | Buy |
64,837
+25,186
| +64% | +$338K | ﹤0.01% | 2816 |
|
2021
Q2 | $870K | Sell |
39,651
-80,000
| -67% | -$1.76M | ﹤0.01% | 2774 |
|
2021
Q1 | $2.88M | Buy |
119,651
+93,056
| +350% | +$2.24M | ﹤0.01% | 1272 |
|
2020
Q4 | $478K | Buy |
26,595
+5,269
| +25% | +$94.7K | ﹤0.01% | 2802 |
|
2020
Q3 | $247K | Buy |
+21,326
| New | +$247K | ﹤0.01% | 3048 |
|
2019
Q4 | – | Sell |
-13,847
| Closed | -$315K | – | 4017 |
|
2019
Q3 | $315K | Buy |
+13,847
| New | +$315K | ﹤0.01% | 2662 |
|
2018
Q4 | – | Sell |
-14,312
| Closed | -$748K | – | 3990 |
|
2018
Q3 | $748K | Buy |
+14,312
| New | +$748K | ﹤0.01% | 1992 |
|